InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (43 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
43
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Mahon Paul A, Executive Vice President, General Counsel, and Corporate Secretary. Director active across 1 company, notably UNITED THERAPEUTICS Corp. Cumulatively, 164 filings have been recorded. Breakdown: 0 buy · 43 sells. Total volume traded: €20.2m. History available since 6 May 2021. The latest transaction was filed on 20 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Mahon Paul A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations164 total
2,690 shares@ US$146.03Common StockSEC:0001231589-26-000018:0
5,610 shares@ US$146.03Common StockSEC:0001231589-26-000018:1
2,690 shares@ US$524.15Common StockSEC:0001231589-26-000018:2
502 shares@ US$520.0331Common StockSEC:0001231589-26-000018:3
1,819 shares@ US$521.0406Common StockSEC:0001231589-26-000018:4
787 shares@ US$522.0036Common StockSEC:0001231589-26-000018:5
850 shares@ US$522.7838Common StockSEC:0001231589-26-000018:6
192 shares@ US$523.6897Common StockSEC:0001231589-26-000018:7
940 shares@ US$525.2504Common StockSEC:0001231589-26-000018:8
400 shares@ US$526.385Common StockSEC:0001231589-26-000018:9
120 shares@ US$527.21Common StockSEC:0001231589-26-000018:10
1,360 shares@ US$515.93030.0027% mcap0.6% of flowCommon StockSEC:0001231589-26-000017:3
8,300 shares@ US$146.030.0047% mcap1.0% of flowCommon StockSEC:0001231589-26-000017:0
780 shares@ US$517.94110.0016% mcap0.3% of flowCommon StockSEC:0001231589-26-000017:5
1,308 shares@ US$521.49720.0026% mcap0.5% of flowCommon StockSEC:0001231589-26-000017:7
760 shares@ US$512.91740.0015% mcap0.3% of flowCommon StockSEC:0001231589-26-000017:1
1,795 shares@ US$514.82230.0036% mcap0.7% of flowCommon StockSEC:0001231589-26-000017:2
1,617 shares@ US$516.92570.0032% mcap0.7% of flowCommon StockSEC:0001231589-26-000017:4
360 shares@ US$518.82310.0007% mcap0.1% of flowCommon StockSEC:0001231589-26-000017:6
320 shares@ US$522.3950.0006% mcap0.1% of flowCommon StockSEC:0001231589-26-000017:8
1,519 shares@ US$534.98910.0036% mcap0.7% of flowCommon StockSEC:0001231589-26-000016:7
80 shares@ US$536.85260.0002% mcap0.0% of flowCommon StockSEC:0001231589-26-000016:8
600 shares@ US$527.5950.0014% mcap0.3% of flowCommon StockSEC:0001231589-26-000016:1
861 shares@ US$531.96920.0020% mcap0.4% of flowCommon StockSEC:0001231589-26-000016:3
800 shares@ US$532.93940.0019% mcap0.4% of flowCommon StockSEC:0001231589-26-000016:4
25 of 164 declarations
About Mahon Paul A
MAHON PAUL A is Executive Vice President, General Counsel, and Corporate Secretary at UNITED THERAPEUTICS Corp, where he is also listed as EVP & GENERAL COUNSEL. Across 135 filings in total, the most recent filings we hold span 2016-01-08 to 2026-04-16, with 0 EUR of buys and 8,862,264 EUR of sells, and the most frequent transaction nature is Levée d'options.
